Christina J. Ramirez
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Christina J. Ramirez has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
- Amy K. LeBlanc
Comparative Oncology Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, USA
14 shared publications - Baris Turkbey
Molecular Imaging Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA
14 shared publications - Christina Mazcko
National Cancer Institute 1 Comparative Oncology Program, Center for Cancer Research National Institutes of Health, Bethesda, Maryland
14 shared publications - Gregory Thomas Brown
Molecular Imaging Branch, National Institutes of Health, Bethesda, Maryland, USA
14 shared publications - Jessica A. Beck
National Cancer Institute 1 Comparative Oncology Program, Center for Cancer Research National Institutes of Health, Bethesda, Maryland
14 shared publications - Joshua D. Mannheimer
National Cancer Institute 1 Comparative Oncology Program, Center for Cancer Research National Institutes of Health, Bethesda, Maryland
14 shared publications
Latest Publications
- Open Access
- 16 December 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Table S3 from Large-Scale Comparative Analysis of Canine and Human Osteosarcomas Uncovers Conserved Clinically Relevant Tumor Microenvironment Subtypes
QuPath (v0.5.0) Macrophage density (number of CD204 positive cells per mm2) outputs for each case that passed quality review.
- 16 December 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S3 from Large-Scale Comparative Analysis of Canine and Human Osteosarcomas Uncovers Conserved Clinically Relevant Tumor Microenvironment Subtypes
QuPath (v0.5.0) Macrophage density (number of CD204 positive cells per mm2) outputs for each case that passed quality review.
- Open Access
- 16 December 2024
- Published by American Association for Cancer Research (AACR)
Data from Large-Scale Comparative Analysis of Canine and Human Osteosarcomas Uncovers Conserved Clinically Relevant Tumor Microenvironment Subtypes
Purpose:Osteosarcoma is an aggressive bone cancer lacking robust biomarkers for personalized treatment. Despite its scarcity in humans, it is relatively common in adult pet dogs. This study aimed to analyze clinically annotated bulk tumor transcriptomic datasets of canine and patients with human osteosarcoma to identify potentially conserved patterns of disease progression.Experimental Design:Bulk transcriptomic data from 245 pet dogs with treatment-naïve appendicular osteosarcoma were analyzed using deconvolution to characterize the tumor microenvironment (TME). The TME of both primary and metastatic tumors derived from the same dog was compared, and its impact on canine survival was assessed. A machine learning model was developed to classify the TME based on its inferred composition using canine tumor data. This model was applied to eight independent human osteosarcoma datasets to assess its generalizability and prognostic value.Results:This study found three distinct TME subtypes of canine osteosarcoma based on cell type composition of bulk tumor samples: immune enriched, immune enriched dense extracellular matrix-like, and immune desert. These three TME-based subtypes of canine osteosarcomas were conserved in humans and could predict progression-free survival outcomes of human patients, independent of conventional prognostic factors such as percent tumor necrosis post standard of care chemotherapy treatment and disease stage at diagnosis.Conclusions:These findings demonstrate the potential of leveraging data from naturally occurring cancers in canines to model the complexity of the human osteosarcoma TME, offering a promising avenue for the discovery of novel biomarkers and developing more effective precision oncology treatments.
- 16 December 2024
- Published by American Association for Cancer Research (AACR)
Open AccessData from Large-Scale Comparative Analysis of Canine and Human Osteosarcomas Uncovers Conserved Clinically Relevant Tumor Microenvironment Subtypes
Purpose:Osteosarcoma is an aggressive bone cancer lacking robust biomarkers for personalized treatment. Despite its scarcity in humans, it is relatively common in adult pet dogs. This study aimed to analyze clinically annotated bulk tumor transcriptomic datasets of canine and patients with human osteosarcoma to identify potentially conserved patterns of disease progression.Experimental Design:Bulk transcriptomic data from 245 pet dogs with treatment-naïve appendicular osteosarcoma were analyzed using deconvolution to characterize the tumor microenvironment (TME). The TME of both primary and metastatic tumors derived from the same dog was compared, and its impact on canine survival was assessed. A machine learning model was developed to classify the TME based on its inferred composition using canine tumor data. This model was applied to eight independent human osteosarcoma datasets to assess its generalizability and prognostic value.Results:This study found three distinct TME subtypes of canine osteosarcoma based on cell type composition of bulk tumor samples: immune enriched, immune enriched dense extracellular matrix-like, and immune desert. These three TME-based subtypes of canine osteosarcomas were conserved in humans and could predict progression-free survival outcomes of human patients, independent of conventional prognostic factors such as percent tumor necrosis post standard of care chemotherapy treatment and disease stage at diagnosis.Conclusions:These findings demonstrate the potential of leveraging data from naturally occurring cancers in canines to model the complexity of the human osteosarcoma TME, offering a promising avenue for the discovery of novel biomarkers and developing more effective precision oncology treatments.
- Open Access
- 16 December 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Table S7 from Large-Scale Comparative Analysis of Canine and Human Osteosarcomas Uncovers Conserved Clinically Relevant Tumor Microenvironment Subtypes
Gene set enrichment analysis results of cancer Hallmark pathways enriched in the IE (Immune Enriched) TME subtype
- 16 December 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S7 from Large-Scale Comparative Analysis of Canine and Human Osteosarcomas Uncovers Conserved Clinically Relevant Tumor Microenvironment Subtypes
Gene set enrichment analysis results of cancer Hallmark pathways enriched in the IE (Immune Enriched) TME subtype
- Open Access
- 16 December 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Table S2 from Large-Scale Comparative Analysis of Canine and Human Osteosarcomas Uncovers Conserved Clinically Relevant Tumor Microenvironment Subtypes
QuPath (v0.5.0) T cell density (number of CD3 positive cells per mm2) outputs for each case that passed quality review.
- 16 December 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S2 from Large-Scale Comparative Analysis of Canine and Human Osteosarcomas Uncovers Conserved Clinically Relevant Tumor Microenvironment Subtypes
QuPath (v0.5.0) T cell density (number of CD3 positive cells per mm2) outputs for each case that passed quality review.
- Open Access
- 16 December 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Table S4 from Large-Scale Comparative Analysis of Canine and Human Osteosarcomas Uncovers Conserved Clinically Relevant Tumor Microenvironment Subtypes
QuPath (v0.5.0) Collagen quantification (%Positive Masson’s Trichrome area) outputs for each case that passed quality review.
- 16 December 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S4 from Large-Scale Comparative Analysis of Canine and Human Osteosarcomas Uncovers Conserved Clinically Relevant Tumor Microenvironment Subtypes
QuPath (v0.5.0) Collagen quantification (%Positive Masson’s Trichrome area) outputs for each case that passed quality review.
- Open Access
- 16 December 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Table S8 from Large-Scale Comparative Analysis of Canine and Human Osteosarcomas Uncovers Conserved Clinically Relevant Tumor Microenvironment Subtypes
Gene set enrichment analysis results of cancer Hallmark pathways enriched in the IE-ECM(Immune Enriched Dense Extra Cellular Matrix-like ) TME subtype
- 16 December 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S8 from Large-Scale Comparative Analysis of Canine and Human Osteosarcomas Uncovers Conserved Clinically Relevant Tumor Microenvironment Subtypes
Gene set enrichment analysis results of cancer Hallmark pathways enriched in the IE-ECM(Immune Enriched Dense Extra Cellular Matrix-like ) TME subtype
- Open Access
- 16 December 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Table S9 from Large-Scale Comparative Analysis of Canine and Human Osteosarcomas Uncovers Conserved Clinically Relevant Tumor Microenvironment Subtypes
Gene set enrichment analysis results of cancer Hallmark pathways enriched in the ID (Immune Desert) TME subtype
- 16 December 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S9 from Large-Scale Comparative Analysis of Canine and Human Osteosarcomas Uncovers Conserved Clinically Relevant Tumor Microenvironment Subtypes
Gene set enrichment analysis results of cancer Hallmark pathways enriched in the ID (Immune Desert) TME subtype
- Open Access
- 16 December 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Table S11 from Large-Scale Comparative Analysis of Canine and Human Osteosarcomas Uncovers Conserved Clinically Relevant Tumor Microenvironment Subtypes
Demographics and progression free survival outcome data of all human patients analyzed in this study.
- 16 December 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S11 from Large-Scale Comparative Analysis of Canine and Human Osteosarcomas Uncovers Conserved Clinically Relevant Tumor Microenvironment Subtypes
Demographics and progression free survival outcome data of all human patients analyzed in this study.
- Open Access
- 16 December 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Table S5 from Large-Scale Comparative Analysis of Canine and Human Osteosarcomas Uncovers Conserved Clinically Relevant Tumor Microenvironment Subtypes
HALO-AI (v3.6) Osteoid quantification (%Positive Osteoid area) outputs for each case that passed quality review.
- 16 December 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S5 from Large-Scale Comparative Analysis of Canine and Human Osteosarcomas Uncovers Conserved Clinically Relevant Tumor Microenvironment Subtypes
HALO-AI (v3.6) Osteoid quantification (%Positive Osteoid area) outputs for each case that passed quality review.
- Open Access
- 16 December 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Document 1 from Large-Scale Comparative Analysis of Canine and Human Osteosarcomas Uncovers Conserved Clinically Relevant Tumor Microenvironment Subtypes
Document containing Supplementary Table legends and supplementary Figures S1-S11
- 16 December 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Document 1 from Large-Scale Comparative Analysis of Canine and Human Osteosarcomas Uncovers Conserved Clinically Relevant Tumor Microenvironment Subtypes
Document containing Supplementary Table legends and supplementary Figures S1-S11